D Amp M Pharma Peru Sac !full!

The Peruvian pharmaceutical market is projected to grow at a CAGR of 5–7% through 2030, driven by an aging population, rising chronic disease prevalence, and expanded healthcare coverage under Universal Health Insurance (SIS). For , several growth avenues exist:

For healthcare buyers: Always cross-reference their RUC, DIGEMID permits, and physical warehouse location before signing contracts. For investors: The "SAC" structure offers limited liability, but due diligence on their import volumes via SUNAT’s Perfil de Riesgo is mandatory. d amp m pharma peru sac

Given the expansion of Peru’s EsSalud and MINSA (Ministry of Health) hospital networks, D amp M Pharma Peru SAC supplies critical injectables, including anesthetics, oncolytics, and emergency resuscitation drugs. The Peruvian pharmaceutical market is projected to grow

In the heart of Lima’s San Isidro district, within a modern office on Av. Pablo Carriquiry 660 Given the expansion of Peru’s EsSalud and MINSA

Trust. Quality. Commitment to health.